Compare SBSW & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBSW | RGEN |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | SBSW | RGEN |
|---|---|---|
| Price | $13.19 | $158.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $6.90 | ★ $170.90 |
| AVG Volume (30 Days) | ★ 4.8M | 723.7K |
| Earning Date | 08-28-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $6,290,132,787.00 | $707,890,000.00 |
| Revenue This Year | $14.61 | $17.84 |
| Revenue Next Year | $15.74 | $12.57 |
| P/E Ratio | ★ N/A | $6,353.06 |
| Revenue Growth | 3.11 | ★ 11.74 |
| 52 Week Low | $3.05 | $102.97 |
| 52 Week High | $13.40 | $182.52 |
| Indicator | SBSW | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.47 | 49.06 |
| Support Level | $12.10 | $160.11 |
| Resistance Level | $12.81 | $165.02 |
| Average True Range (ATR) | 0.52 | 4.83 |
| MACD | 0.05 | -1.19 |
| Stochastic Oscillator | 66.67 | 3.00 |
Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.